Telios Pharma is a privately held clinical stage biopharmaceutical company with first-in-class topical and oral BTK inhibitor programs targeting mast cell-mediated inflammation and allergy.
Launched in 2019 by proven industry veterans, we have brought together a team of scientists and clinicians with deep therapeutic expertise, and an experienced leadership team.
We are passionate, collaborative and dedicated to our mission of improving the lives of patients with inflammatory diseases.
Company Details
- Employees
- 38
- Founded
- 2019
- Address
- 275 Shoreline Drive,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Inflammatory Diseases, Allergy, Oncology.
- HQ
- Redwood City, California
Telios Pharma, Inc. Questions
Telios Pharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/telios-pharma-inc
Telios Pharma, Inc. has
38 employees.
View email and phone details for 38
employees at Telios Pharma, Inc..
Telios Pharma, Inc.'s industry is
Biotechnology Research
Telios Pharma, Inc.'s top competitors are
Neurocrine Biosciences,
Revolution Medicines,
Summit Therapeutics, Inc.,
Terns Pharmaceuticals,
Vera Therapeutics, Inc.,
Vertex Pharmaceuticals,
Kartos Therapeutics, Inc.,
Corcept Therapeutics,
Gilead Sciences,
Biomea Fusion.
Telios Pharma, Inc.'s categories are Biotechnology Research
Telios Pharma, Inc.'s founding year is 2019
